The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 RECOURSE trial of TAS-102 versus placebo with best supportive care in patients with metastatic colorectal cancer: Geographic subgroups.
 
Atsushi Ohtsu
Employment - Celgene
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Merck Serono; Taiho Pharmaceutical
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Takeda
Research Funding - Daiichi Sankyo; Dainippon Sumitomo Pharma; Lilly; Pfizer; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Mona M. Wahba
Employment - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Fabio M. Benedetti
Employment - Taiho Pharmaceutical
Leadership - Taiho Pharmaceutical
 
Robert J. Mayer
Honoraria - Amgen; AstraZeneca
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)